A multicentre, open-label, phase-I/randomised phase-II study to evaluate safety, pharmacokinetics, and efficacy of nintedanib vs. sorafenib in European patients with advanced hepat... von Palmer, D. H., Ma, Y. T., Peck-Radosavljevic, M., Ross, P., Graham, J., Fartoux, L., Deptala, A., Studeny, M., Schnell, D., Hocke, J., Loembé, A-B., Meyer, T.

Volltext

Phase II study of ceralasertib (AZD6738) in combination with durvalumab in patients with advanced/metastatic melanoma who have failed prior anti-PD-1 therapy von Kim, R., Kwon, M., An, M., Kim, S.T., Smith, S.A., Loembé, A.B., Mortimer, P.G.S., Armenia, J., Lukashchuk, N., Shah, N., Dean, E., Park, W.-Y., Lee, J.

Volltext

Phase I evaluation of telatinib, a VEGF receptor tyrosine kinase inhibitor, in combination with bevacizumab in subjects with advanced solid tumors von Langenberg, M.H.G., Witteveen, P.O., Roodhart, J., Lolkema, M.P., Verheul, H.M.W., Mergui-Roelvink, M., Brendel, E., Krätzschmar, J., Loembé, B., Nol-Boekel, A., Christensen, O., Schellens, J.H.M., Voest, E.E.

Volltext

A randomised, phase II study of nintedanib or sunitinib in previously untreated patients with advanced renal cell cancer: 3-year results von Eisen, T, Loembé, A-B, Shparyk, Y, MacLeod, N, Jones, R J, Mazurkiewicz, M, Temple, G, Dressler, H, Bondarenko, I

Volltext

821TiP Phase I study of ceralasertib (cerala) in combination with AZD5305 in patients (pts) with advanced/metastatic ovarian cancer (OC) previously treated with PARP inhibitors (PA... von Shapiro, G.I., Basu, B., El-Khoueiry, A.B., Postel-Vinay, S., Im, S-A., Rha, S.Y., Friedman, C.F., Italiano, A., Kim, Y.M., Lim, M-C., Roux, R., Liu, J.F., Brown, M., Webb, B.W., Lukashchuk, N., Dean, E.J., Nehra, J., Loembé, B., Krebs, M.G.

Volltext

PD-005 Combined analysis of two randomised Phase II trials comparing the efficacy and safety of nintedanib versus sorafenib in Caucasian and Asian patients with advanced hepatocell... von Palmer, D., Meyer, T., Chao, Y., Deptala, A., Fartoux, L., Feng, Y.-H., Graham, J., Lin, D.-Y., Ma, Y.T., Peck-Radosavljevic, M., Ross, P., Ryoo, B.-Y., Yen, C.-J., Hocke, J., Vlassak, S., Wenz, A., Loembe, A.-B., Cheng, A.-L.

Volltext

mRECIST to predict survival in advanced hepatocellular carcinoma: Analysis of two randomised phase II trials comparing nintedanib vs sorafenib von Meyer, T, Palmer, DH, Cheng, A-L, Hocke, J, Loembé, A-B, Yen, C-J

Volltext bestellen

Nintedanib Plus Pemetrexed/Cisplatin in Patients With Malignant Pleural Mesothelioma: Phase II Results From the Randomized, Placebo-Controlled LUME-Meso Trial von Grosso, F, Steele, N, Novello, S, Nowak, AK, Popat, S, Greillier, L, John, T, Leighl, NB, Reck, M, Taylor, P, Planchard, D, Sorensen, JB, Socinski, MA, Von Wangenheim, U, Loembe, AB, Barrueco, J, Morsli, N, Scagliotti, G

Volltext

A multicentre, open-label, phase-I/randomised phase-II study to evaluate safety, pharmacokinetics, and efficacy of nintedanib vs. sorafenib in European patients with advanced hepat... von Palmer, DH, Ma, YT, Peck-Radosavljevic, M, Ross, P, Graham, J, Fartoux, L, Deptala, A, Studeny, M, Schnell, D, Hocke, J, Loembé, A-B, Meyer, T

Volltext bestellen

A phase I study of nintedanib combined with cisplatin/gemcitabine as first-line therapy for advanced squamous non-small cell lung cancer (LUME-Lung 3) von Forster, M, Hackshaw, A, De Pas, T, Cobo, M, Garrido, P, Summers, Y, Dingemans, AMC, Flynn, M, Schnell, D, von Wangenheim, U, Loembé, AB, Kaiser, R, Lee, SM

Volltext bestellen

Supplementary Material for: A Phase I/Randomized Phase II Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Nintedanib versus Sorafenib in Asian Patients with Advance... von Yen, C.-J., Kim, T.-Y., Feng, Y.-H., Chao, Y., Lin, D.-Y., Ryoo, B.-Y., D.C.-L., Huang, Schnell, D., Hocke, J., Loembé, A.-B., Cheng, A.-L.

Volltext bestellen

Surveillance of the major pathogenic arboviruses of public health concern in Gabon, Central Africa: increased risk of West Nile virus and dengue virus infections von Ushijima, Yuri, Abe, Haruka, Nguema Ondo, Georgelin, Bikangui, Rodrigue, Massinga Loembé, Marguerite, Zadeh, Vahid R, Essimengane, Joseph G E, Mbouna, Armel V N, Bache, Emmanuel B, Agnandji, Selidji T, Lell, Bertrand, Yasuda, Jiro

Volltext

Lack of elevated pre-ART elastase-ANCA levels in patients developing TB-IRIS von Goovaerts, Odin, Massinga-Loembé, Marguerite, Ondoa, Pascale, Ceulemans, Ann, Worodria, William, Mayanja-Kizza, Harriet, Colebunders, Robert, Kestens, Luc

Volltext

Nintedanib Plus Pemetrexed/Cisplatin in Patients With Malignant Pleural Mesothelioma: Phase II Results From the Randomized, Placebo-Controlled LUME-Meso Trial von Grosso, Federica, Steele, Nicola, Novello, Silvia, Nowak, Anna K, Popat, Sanjay, Greillier, Laurent, John, Thomas, Leighl, Natasha B, Reck, Martin, Taylor, Paul, Planchard, David, Sørensen, Jens Benn, Socinski, Mark A, von Wangenheim, Ute, Loembé, Arsène Bienvenu, Barrueco, José, Morsli, Nassim, Scagliotti, Giorgio

Volltext

Increased KLRG1 and PD-1 expression on CD8 T lymphocytes in TB-IRIS von Goovaerts, Odin, Massinga-Loembé, Marguerite, Ondoa, Pascale, Ceulemans, Ann, Worodria, William, Mayanja-Kizza, Harriet, Colebunders, Robert, Kestens, Luc

Volltext

Bacterial versus non-bacterial infections: a methodology to support use-case-driven product development of diagnostics von Escadafal, Camille, Geis, Steffen, Siqueira, A M, Agnandji, Selidji T, Shimelis, Techalew, Tadesse, Birkneh Tilahun, Massinga Loembé, Marguerite, Harris, Victoria, Fernandez-Carballo, B Leticia, Macé, Aurélien, Ongarello, Stefano, Rodriguez, William, Dittrich, Sabine

Volltext

Lack of Effectiveness of Cellulose Sulfate Gel for the Prevention of Vaginal HIV Transmission von Van Damme, Lut, Govinden, Roshini, Mirembe, Florence M, Guédou, Fernand, Solomon, Suniti, Becker, Marissa L, Pradeep, B.S, Krishnan, A.K, Alary, Michel, Pande, Bina, Ramjee, Gita, Deese, Jennifer, Crucitti, Tania, Taylor, Doug

Volltext

LPS-binding protein and IL-6 mark paradoxical tuberculosis immune reconstitution inflammatory syndrome in HIV patients von Goovaerts, Odin, Jennes, Wim, Massinga-Loembé, Marguerite, Ceulemans, Ann, Worodria, William, Mayanja-Kizza, Harriet, Colebunders, Robert, Kestens, Luc

Volltext

Lower Pre-Treatment T Cell Activation in Early- and Late-Onset Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome von Goovaerts, Odin, Jennes, Wim, Massinga-Loembé, Marguerite, Ondoa, Pascale, Ceulemans, Ann, Vereecken, Chris, Worodria, William, Mayanja-Kizza, Harriet, Colebunders, Robert, Kestens, Luc

Volltext

Tuberculosis Treatment Outcome and Drug Resistance in Lambaréné, Gabon: A Prospective Cohort Study von Bélard, Sabine, Remppis, Jonathan, Bootsma, Sanne, Janssen, Saskia, Kombila, Davy U, Beyeme, Justin O, Rossatanga, Elie G, Kokou, Cosme, Osbak, Kara K, Obiang Mba, Régis M, Kaba, Harry M, Traoré, Afsatou N, Ehrhardt, Jonas, Bache, Emmanuel B, Flamen, Arnaud, Rüsch-Gerdes, Sabine, Frank, Matthias, Adegnika, Ayôla A, Lell, Bertrand, Niemann, Stefan, Kremsner, Peter G, Loembé, Marguerite M, Alabi, Abraham S, Grobusch, Martin P

Volltext